Clinical Report: Associations Between Atherogenic Index and All-Cause Mortality

Overview

This study investigates the association between the Atherogenic Index of Plasma (AIP) and all-cause mortality in hypertensive and non-hypertensive individuals over a median follow-up of 8.82 years. Findings indicate that AIP and its modified indices are significantly associated with reduced mortality risk in hypertensive individuals, while no significant associations were observed in non-hypertensive individuals.

Background

Incorporate relevant statistics or studies to substantiate claims about CVD in low-income populations.

Data Highlights

Key Findings

• AIP and its modified indices are significantly negatively associated with all-cause mortality in hypertensive individuals.
• A one-unit increase in AIP-WHtR is associated with a 79% reduction in mortality risk.
• A one-unit increase in AIP is associated with a 57% reduction in mortality risk.
• No significant associations between AIP and all-cause mortality were found in the non-hypertensive group.
• AIP and its modified indices demonstrated better predictive ability for all-cause mortality compared to the TyG index.

Clinical Implications

Healthcare professionals should consider the Atherogenic Index of Plasma (AIP) as a potential biomarker for assessing mortality risk in hypertensive patients. The findings suggest that monitoring AIP levels may aid in identifying individuals at higher risk for all-cause mortality, thereby informing preventive strategies in rural and low-income populations.

Conclusion

Highlight specific areas for future research to enhance understanding of AIP's role.

Related Resources & Content

1. American Journal of Epidemiology, 2023 -- Exploring the Inverse Relationship Between LDL-C Levels and Hemorrhagic Stroke Risk in Hypertensive Chinese Adults
2. Frontiers in Endocrinology, 2023 -- The role of albumin–globulin ratio in peripheral arterial disease among hypertensive adults
3. Clinical Research in Cardiology, 2023 -- Linking the C-reactive protein-triglyceride glucose index to cardiovascular and overall mortality risk in older adults
4. Frontiers in Endocrinology, 2023 -- BMI-specific nonlinear associations and threshold effects of the atherogenic index of plasma on incident prediabetes
5. Development and Validation of AHA’s PREVENT Equations - American College of Cardiology, 2024
6. 2024 ESC Guidelines for Management of Elevated BP and Hypertension: Key Points - American College of Cardiology
7. Development and Validation of AHA’s PREVENT Equations - American College of Cardiology
8. 2024 ESC Guidelines for Management of Elevated BP and Hypertension: Key Points - American College of Cardiology